ANDA 79206, held by Chartwell Rx. Topiramate.
As of Nov 15, 2026, ANDA 79206 (Topiramate), held by Chartwell Rx, was first approved by FDA on Oct 14, 2009, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 14, 2009 | Original application | Approved | None posted |
| Topiramate15MG · capsule;oral | Topiramate | Discontinued |
| Topiramate25MG · capsule;oral | Topiramate | Discontinued |
| Nov 17, 2014 | Supplement 1Labeling | Approved | None posted |
| Nov 17, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 14, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters